Current portfolio

Agomab Therapeutics

Agomab Therapeutics is a biotechnology company developing therapies that aim to preserve and restore organ function in fibrotic diseases

  • Sector
    Healthcare
  • Country
    Belgium
  • Fund
    LSP 7
  • Entry
    2023
  • Web
Logo
0
EQT logo